Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Author name: EASL

EASL Congress

LIVERAIM related activities at EASL Congress 2025

This ambitious collaboration between academic, clinical, and industry partners aims to transform how liver diseases are diagnosed and treated by developing innovative and cost-effective tools for early diagnosis and personalized care, with the goal of improving patient outcomes. [vc_custom_headin…

EASL Congress

LiverScreen related activities at EASL Congress 2025

The ambition of the LiverScreen Consortium has been realised with the screening of more than 30.000 participants from the general population across 9 different European Countries and the development & validation of the Liver Risk Score, bringing forward significant new & important knowledge to th…

EASL Congress

DECISION related activities at EASL Congress 2025

DECISION strives to better understand the pathophysiology of decompensated cirrhosis leading to acute-on-chronic liver failure (ACLF) at the systems level by taking advantage of already existing large and clinically well-characterized patient cohorts. The ultimate goal is to significantly reduce …

EASL Congress

MICROB-PREDICT related activities at EASL Congress 2025

22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensa…

EASL Congress

A-TANGO related activities at EASL Congress 2025

A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients who never recover fully and require long-term care.[vc_custom_heading text=”Wednesday…

EASL News

New EASL Clinical Practice Guidelines on TIPS

EASL has published its first Clinical Practice Guidelines dedicated to transjugular intrahepatic portosystemic shunt (TIPS), providing comprehensive, evidence-based recommendations on the use of TIPS in patients with cirrhosis. Key advancements Owing to its established role in the management of c…

Scroll to Top

Search EASL